The GTF2I rs117026326 polymorphism is associated with anti-SSA-positive primary Sjögren's syndrome

Rheumatology (United Kingdom)

Volumn 54, Issue 3, 2015, Pages 562-564

  Zheng, Junfeng ^a   Huang, Renliang ^a   Huang, Qiaoniang ^a   Deng, Fengyuan ^a   Chen, Yan ^a   Yin, Junping ^a   Chen, Juan ^a   Wang, Ying ^a   Shi, Guixiu ^a   Gao, Xing ^a   Liu, Zuguo ^a   Petersen, Frank ^b   Yu, Xinhua ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b Member of the German Center for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GENERAL TRANSCRIPTION FACTOR; GENERAL TRANSCRIPTION FACTOR 2I; LA ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ALLELE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAN CHINESE; HLA SYSTEM; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SJOEGREN SYNDROME;

EID: 84941637468     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu466     Document Type: Letter

References (8)

1. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the AmericanEuropean Consensus Group. Ann Rheum Dis 2002;61:554-8.
2. Li Y, Zhang K, Chen H et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet 2013; 45:1361-5.
3. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011; 365:1612-23.
4. Han JW, Zheng HF, Cui Y et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009;41:1234-7.
5. Lessard CJ, Li H, Adrianto I et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013; 45:1284-92.
6. Sacristán C, Schattgen SA, Berg LJ et al. Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells. Eur J Immunol 2009;39:2584-95.
7. Yang W, Desiderio S. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc Natl Acad Sci U S A 1997;94:604-9.
8. Ren X, Siegel R, Kim U, Roeder RG. Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication. Mol Cell 2011;42:342-55.